Glial fibrillary acidic protein (GFAP), a key astrocytic cytoskeletal component, is released into the cerebrospinal fluid (CSF) during neuroinflammation and serves as a well-established marker of neurodegenerative diseases, including AD [4]. This evidence concerns the gene GFAP and Alzheimer disease.